Docaravimab + Miromavimab
Uses
Docaravimab and Miromavimab are used in the treatment of rabies.
How it Works
How Docaravimab and Miromavimab Work Rabies is a viral infection caused by the rabies virus, which primarily affects the nervous system. Once the virus enters the body through a bite from an infected animal, it travels along nerve fibers to the central nervous system, including the brain. There, it can cause severe neurological symptoms and, ultimately, death if left untreated. Docaravimab and Miromavimab contain two antibodies: docaravimab and miromavimab. These antibodies bind to the rabies virus and prevent it from entering and infecting nerve cells and other cells in the body. This interruption of the virus's ability to replicate and spread within the body is crucial for halting the progression of rabies infection.
Side Effects
Common side effects of Docaravimab and Miromavimab include injection site reactions such as pain, swelling, and redness.
Expert Advice
- All cases of rabies exposure should be treated immediately to prevent clinical symptoms and death.
- Docaravimab + Miromavimab is prescribed for post-exposure risk prevention after contact with:
- An infected animal
- An animal suspected to have rabies infection
- No skin sensitivity test is required.
- Docaravimab + Miromavimab should be administered by a trained healthcare professional.
- Follow the recommended dosing schedule.
